TR200103531T2 - Trisklik analjezikler - Google Patents

Trisklik analjezikler

Info

Publication number
TR200103531T2
TR200103531T2 TR2001/03531T TR200103531T TR200103531T2 TR 200103531 T2 TR200103531 T2 TR 200103531T2 TR 2001/03531 T TR2001/03531 T TR 2001/03531T TR 200103531 T TR200103531 T TR 200103531T TR 200103531 T2 TR200103531 T2 TR 200103531T2
Authority
TR
Turkey
Prior art keywords
tricyclic
analgesics
cns
discomfort
indications
Prior art date
Application number
TR2001/03531T
Other languages
English (en)
Inventor
Calvet Alain
Jacobelli Henri
Puaud Jocelyne
J. Roman Fran�Ois
Hamon Jacques
Grouhel Agn�S
Original Assignee
Warner Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Company filed Critical Warner Lambert Company
Publication of TR200103531T2 publication Critical patent/TR200103531T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Bu bulus bir formül (I) trisiklik bilesimi ve bunun tuzlari ile ilgilidir. Söz konusu bilesim diger endikasyonlarin yaninda özellikle nöropatik agri ve diger CNS rahatsizliklarini tedavi etmek için kullanislidir.
TR2001/03531T 1999-06-07 2000-06-07 Trisklik analjezikler TR200103531T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13786899P 1999-06-07 1999-06-07

Publications (1)

Publication Number Publication Date
TR200103531T2 true TR200103531T2 (tr) 2002-06-21

Family

ID=22479397

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03531T TR200103531T2 (tr) 1999-06-07 2000-06-07 Trisklik analjezikler

Country Status (21)

Country Link
EP (1) EP1235808A2 (tr)
JP (1) JP2003513006A (tr)
KR (1) KR20020010923A (tr)
CN (1) CN1635998A (tr)
AP (1) AP2001002356A0 (tr)
AU (1) AU6428400A (tr)
BG (1) BG106162A (tr)
BR (1) BR0011427A (tr)
CA (1) CA2376076A1 (tr)
EA (1) EA200101117A1 (tr)
HR (1) HRP20010913A2 (tr)
HU (1) HUP0203317A2 (tr)
IL (1) IL146755A0 (tr)
IS (1) IS6175A (tr)
MA (1) MA26795A1 (tr)
MX (1) MXPA01012694A (tr)
NO (1) NO20015966D0 (tr)
PL (1) PL357340A1 (tr)
SK (1) SK17512001A3 (tr)
TR (1) TR200103531T2 (tr)
WO (1) WO2000075116A2 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
FR2915099B1 (fr) * 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
MX355907B (es) * 2011-02-02 2018-05-04 Vertex Pharma Pirrolopirazina-piperidina espirociclica-amidas como moduladores de canales de ionicos.
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
CN115872873B (zh) * 2022-12-29 2024-11-29 上海泰坦科技股份有限公司 一种双(2-溴乙基)胺氢溴酸盐的重结晶纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917069D0 (en) * 1989-07-26 1989-09-13 Merck Sharp & Dohme Therapeutic agents
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
DE69412067T2 (de) * 1993-01-28 1999-03-25 Merck & Co., Inc., Rahway, N.J. Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
AU5604998A (en) * 1996-12-13 1998-07-03 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
AP2001002356A0 (en) 2001-12-31
CN1635998A (zh) 2005-07-06
WO2000075116A3 (en) 2002-07-04
JP2003513006A (ja) 2003-04-08
KR20020010923A (ko) 2002-02-06
BR0011427A (pt) 2002-03-26
EP1235808A2 (en) 2002-09-04
MA26795A1 (fr) 2004-12-20
BG106162A (bg) 2002-05-31
NO20015966L (no) 2001-12-06
AU6428400A (en) 2000-12-28
IS6175A (is) 2001-11-23
EA200101117A1 (ru) 2002-06-27
WO2000075116A2 (en) 2000-12-14
PL357340A1 (en) 2004-07-26
IL146755A0 (en) 2002-07-25
CA2376076A1 (en) 2000-12-14
HUP0203317A2 (hu) 2003-02-28
NO20015966D0 (no) 2001-12-06
HRP20010913A2 (en) 2003-04-30
SK17512001A3 (sk) 2002-11-06
MXPA01012694A (es) 2003-10-15

Similar Documents

Publication Publication Date Title
TR200402577T4 (tr) Urasil bileşikleri ve bunların kullanımları
PT1109812E (pt) Pirrolobenzodiazepinas
TR199903287T2 (tr) Matriks metaloproteinazlarinin ters hidroksamat inhibitörleri.
YU20199A (sh) Heterociklični sukcinimidi i njihova primena kao metaloproteinaznih inhibitora
GB9919776D0 (en) Compoujnds
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
TR200101893T2 (tr) Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.
BG106585A (en) Kinase inhibitors as therapeutic agents
IN2012DN00606A (tr)
ATE227264T1 (de) Metalloproteinase-inhibitoren
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
HRP20050516B1 (hr) N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
TR199901680T2 (tr) Nitrik oksit sentaz inhibitörleri.
AU2864002A (en) Compounds having fungicidal activity and processes to make and use same
BR9810459A (pt) sais nìtricos dos inibidores de ace
TR200100700T2 (tr) EtO2C--CH2-(R)Cgl-Aze-Pab-OH'nin kristalin formları
GB9715030D0 (en) Metalloproteinase inhibitors
TR199902283T2 (tr) Ikame edilmis izokuinolin türevleri ve bunlarin antikonvulsant olarak kullanimi.
YU30502A (sh) Herbicidna sredstva
FR2818906B1 (fr) Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
TR200103531T2 (tr) Trisklik analjezikler
TR200003859T2 (tr) Amidino ve guanidino azetidinon triptaz önleyicileri
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
BR0115996A (pt) Sulfamidotienopirimidinas
NO995289D0 (no) Benzimidazol-derivater